title: Application prospect and clinical effect analysis of Fu Chan Xue Jing during bleeding after abortion.
abstract: To investigate the application future of Fu Chan Xue Jing during bleeding after abortion and to observe the clinical effect analysis of Fu Chan Xue Jing on the treatment of bleeding after medical abortion. 86 patients who were willing to perform medical abortion in Women and infants Hospital of Zhengzhou from December 2013 to November 2014 were randomly divided into two groups, with 43 cases in either observation group or control group. Basic medical abortion was conducted on the patients in control group, apart from which Fu Chan Xue Jing was added on the patients in observation group. Meanwhile, the vaginal bleeding volume and vaginal bleeding time for patients in both groups were observed and compared. The treatment results showed that the vaginal bleeding volume for patients in treatment group was lower than that in control group, showing statistically significant difference (P<0.05); the average time (7.5 ± 1.3 d) of vaginal bleeding for patients in treatment group was shorter than that (13.5 ± 4.1d) in control group, showing statistically significant difference for the data of the two groups (P<0.05). Fu Chan Xue Jing is conducive to reduce the bleeding after abortion and help to recovery the normal menstruation faster, which has good effects to prevent the bleeding volume after medical abortion and control the bleeding time, worth popularizing on clinic.
authors.affiliation: Department of Obstetrics and Gynecology, Maternal and Child Hospital of Zhengzhou City, China.
authors.forename: Pu
authors.initials: P
authors.lastname: Wen
authors.affiliation: Department of Obstetrics and Gynecology, Maternal and Child Hospital of Zhengzhou City, China.
authors.forename: Wei
authors.initials: W
authors.lastname: Cui
authors.affiliation: Department of Obstetrics and Gynecology, Maternal and Child Hospital of Zhengzhou City, China.
authors.forename: Jun
authors.initials: J
authors.lastname: Cui
authors.affiliation: Department of Obstetrics and Gynecology, Maternal and Child Hospital of Zhengzhou City, China.
authors.forename: Xue
authors.initials: X
authors.lastname: Shao
mesh_terms: D000021:Abortifacient Agents, Steroidal; D000028:Abortion, Induced / Q000009:adverse effects*; D000328:Adult; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008598:Menstruation; D015735:Mifepristone; D019106:Postoperative Hemorrhage / Q000188:drug therapy*; D011247:Pregnancy; D014592:Uterine Hemorrhage / Q000188:drug therapy / Q000209:etiology; D055815:Young Adult
chemical_list: D000021:Abortifacient Agents, Steroidal; D004365:Drugs, Chinese Herbal; C000603633:Fu Chan Xue Jing; D015735:Mifepristone